European journal of immunology · 2008
Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Heit Antje, Gebhardt Friedemann, Lahl Katharina, Neuenhahn Michael, Schmitz Frank, Anderl Florian, Wagner Hermann, Sparwasser Tim, Busch Dirk H, Kastenmüller Kathrin
Аннотация
Immunization with purified antigens is a safe and practical vaccination strategy but is generally unable to induce sustained CD8(+) T cell-mediated protection against intracellular pathogens. Most efforts to improve the CD8(+) T cell immunogenicity of these vaccines have focused on co-administration of adjuvant to support cross-presentation and dendritic cell maturation. In addition, it has been shown that CD4(+) T cell help during the priming phase contributes to the generation of protective CD8(+) memory T cells. In this report we demonstrate that the depletion of CD4(+) T cells paradoxically enhances long-lasting CD8-mediated protective immunity upon protein vaccination. Functional and genetic in vivo inactivation experiments attribute this enhancement primarily to MHC class II-restricted CD4(+) regulatory T cells (Treg), which appear to physiologically suppress the differentiation process towards long-living effector memory T cells. Since, in functional terms, this suppression by Treg largely exceeds the positive effects of conventional CD4(+) T cell help, even the absence of all CD4(+) T cells or lack of MHC class II-mediated interactions on priming dendritic cells result in enhanced CD8(+) T cell immunogenicity. These findings have important implications for the improvement of vaccines against intracellular pathogens or tumors, especially in patients with highly active Treg.
Предметные рубрики MeSH
AnimalsAntibodies, MonoclonalBacterial ProteinsBacterial ToxinsCD4 AntigensCD8-Positive T-LymphocytesCross-PrimingDendritic CellsForkhead Transcription FactorsHeat-Shock ProteinsHemolysin ProteinsHistocompatibility Antigens Class IIHumansInterleukin-2 Receptor alpha SubunitListeriosisLymphocyte DepletionMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMice, TransgenicNuclear ProteinsOvalbuminPhosphoproteinsSpleenT-Lymphocytes, RegulatoryTrans-ActivatorsVaccinationViral Matrix Proteins